IR@PKUHSC  > 北京大学第三临床医学院
学科主题临床医学
Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma
Chen, Wenming1; Wei, Peng2; Yang, Shifang2; Zheng, Xiangjun2; Qiu, Lugui3,4,5; Hou, Jian6; Zhang, Xuejun7; Wang, Zhao8; Ke, Xiaoyan9; Pan, Ling10; Pang, Hongyan2
刊名BLOOD
2014-12-06
124期:21
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Hematology
研究领域[WOS]Hematology
语种英语
WOS记录号WOS:000349243505067
Citation statistics
Cited Times:1[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63177
Collection北京大学第三临床医学院
作者单位1.Sichuan Univ, West China Hosp, Chengdu 610064, Peoples R China
2.Capital Med Univ, Chaoyang Hosp, Beijing, Peoples R China
3.Beijing Sunbio Biotech Co Ltd, Beijing, Peoples R China
4.Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China
5.Shanghai Changzheng Hosp, Shanghai, Peoples R China
6.Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China
7.Peking Univ, Hosp 3, Beijing 100871, Peoples R China
8.Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
9.Peking Union Med Coll, Tianjin, Peoples R China
10.Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
Recommended Citation
GB/T 7714
Chen, Wenming,Wei, Peng,Yang, Shifang,et al. Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma[J]. BLOOD,2014,124(21).
APA Chen, Wenming.,Wei, Peng.,Yang, Shifang.,Zheng, Xiangjun.,Qiu, Lugui.,...&Pang, Hongyan.(2014).Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma.BLOOD,124(21).
MLA Chen, Wenming,et al."Transiently Elevated AST/LDH Are Associated with Clinical Response to Recombinant Circularly Permuted TRAIL (CPT) Plus Thalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma".BLOOD 124.21(2014).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Chen, Wenming]'s Articles
[Wei, Peng]'s Articles
[Yang, Shifang]'s Articles
百度学术
百度学术Similar articles in
[Chen, Wenming]'s Articles
[Wei, Peng]'s Articles
[Yang, Shifang]'s Articles
必应学术
必应学术Similar articles in
[Chen, Wenming]'s Articles
[Wei, Peng]'s Articles
[Yang, Shifang]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.